Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?
Critical Reviews in Immunology · 2018 · 38 (4) · 253-261
DOI: 10.1615/critrevimmunol.2018025874 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Critical Reviews in Immunology, 2018. Verfasst von Baohong Zhao. Beteiligte Einrichtung: Arthritis and Tissue Degeneration Program and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, Graduate Program in Biochem…. Die Arbeit wurde bisher 30-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.
Abstract (Originalsprache)
Chronic inflammation is one of the most evident and common pathological conditions leading to deregulated osteoclastogenesis and bone remodeling. Tumor necrosis factor (TNF) as a pleiotropic cytokine plays a key role, not only in inflammation, but also in bone erosion in diseases associated with bone loss. TNF can stimulate the proliferation of osteoclast precursors and, in most conditions, act together with other cytokines and growth factors such as receptor activator of nuclear factor (NF)-[kappa]B ligand (RANKL), interleukin-6, and transforming growth factor beta to synergistically promote osteoclast formation and bone resorption in vivo. A longstanding enigma in the field is why TNF alone is not able to induce osteoclast differentiation as effectively as the same superfamily member RANKL, a physiological master osteoclastogenic cytokine. Recent studies have highlighted several lines of evidence showing the intrinsic mechanisms through RBP-J, NF-[kappa]B p100/TNF receptor-associated factor 3, or interferon regulatory factor-8 that restrain TNF-induced osteoclast differentiation and bone resorption. These feedback inhibitory mechanisms driven by TNF shed light into the current paradigm of osteoclastogenesis and would provide novel therapeutic implications on controlling inflammatory bone resorption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Arthritis and Tissue Degeneration Program and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, Graduate Program in Biochemistry, Cell and Molecular Biology, Weill Cornell Graduate School of Me…
Förderung
- NIAMS NIH HHS
Zitieren
APA
Zhao, B. (2018). Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?. Critical Reviews in Immunology, 38(4), 253-261. https://doi.org/10.1615/critrevimmunol.2018025874
Vancouver
Zhao B. Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?. Critical Reviews in Immunology. 2018;38(4):253-261. doi:10.1615/critrevimmunol.2018025874
BibTeX
@article{Zhao2018,
author = {Zhao, Baohong},
title = {Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?},
journal = {Critical Reviews in Immunology},
year = {2018},
volume = {38},
number = {4},
pages = {253--261},
doi = {10.1615/critrevimmunol.2018025874}
}
EUVIMED